Fokas E, Schlenska-Lange A, Polat B, Klautke G, Grabenbauer GG, Fietkau R, Kuhnt T, Staib L, Brunner T, Grosu AL, Kirste S, Jacobasch L, Allgaeuer M, Flentje M, Germer CT, Grützmann R, Hildebrandt G, Schwarzbach M, Bechstein WO, Suelberg H, Friede T, Gaedcke J, Ghadimi M, Hofheinz RD, Roedel C (2021)
Publication Type: Journal article
Publication year: 2021
DOI: 10.1001/jamaoncol.2021.5445
IMPORTANCE Total neoadjuvant therapy has been increasingly adopted for multimodal rectal cancer treatment. The optimal sequence of chemoradiotherapy (CRT) and chemotherapy needs to be established.
APA:
Fokas, E., Schlenska-Lange, A., Polat, B., Klautke, G., Grabenbauer, G.G., Fietkau, R.,... Roedel, C. (2021). Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. JAMA Oncology. https://doi.org/10.1001/jamaoncol.2021.5445
MLA:
Fokas, Emmanouil, et al. "Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial." JAMA Oncology (2021).
BibTeX: Download